VITAMIN-K3-INDUCED CELL-CYCLE ARREST AND APOPTOTIC CELL-DEATH ARE ACCOMPANIED BY ALTERED EXPRESSION OF C-FOS AND C-MYC IN NASOPHARYNGEAL CARCINOMA-CELLS

被引:0
|
作者
WU, FYH
CHANG, NT
CHEN, WJ
JUAN, CC
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin K3 is known to inhibit the growth of various rodent and human tumor cells. However, the molecular mechanism of its action is still elusive. We have found that vitamin K3 induces cell cycle arrest and apoptotic cell death in nasopharyngeal carcinoma (NPC) cells, as evaluated by flow cytometry and DNA gel electrophoresis. Involvement of c-fos and c-myc proto-oncogenes and expression of their proto-oncoproteins in VK3-induced cell cycle arrest and apoptosis were also investigated. Northern blot analysis of NPC cells treated with 50 mum VK3 showed that c-fos was transiently induced for 60 min after treatment, while c-myc was persistently induced for 1-9 h after drug treatment. Western blot analysis also showed that c-Fos was induced at 4-6 h and at 1-4 h after treatment with 50 mum and 200 mum VK3 respectively, while c-Myc was induced at 1-6 h and at 4-6 h, respectively, after such treatments. These results suggest that the expression of c-fos and c-myc may play an important role in the signaling mechanism of VK3-induced growth arrest and apoptotic cell death.
引用
收藏
页码:2237 / 2244
页数:8
相关论文
共 50 条
  • [21] INTERLEUKIN-3 DEPENDENT C-MYC PROTEIN EXPRESSION DURING THE CELL-CYCLE OF MURINE MAST-CELLS
    MINKS, M
    DIVINCI, A
    BRUNO, S
    GEIDO, E
    AVIGNOLO, C
    GIARETTI, W
    CANCER LETTERS, 1992, 62 (03) : 243 - 249
  • [22] c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells
    Zhang, Dongdong
    Qi, Junpeng
    Liu, Rui
    Dai, Bingling
    Ma, Weina
    Zhan, Yingzhuan
    Zhang, Yanmin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (03): : 1076 - 1088
  • [23] C-Myc regulates radiation-induced G2/M cell cycle arrest and cell death in human cervical cancer cells
    Cui, Fengmei
    Hou, Jun
    Huang, Chengcheng
    Sun, Xiujin
    Zeng, Yanan
    Cheng, Huiying
    Wang, Hao
    Li, Chao
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (04) : 729 - 735
  • [24] CHANGES IN C-MYC EXPRESSION AND THE KINETICS OF DEXAMETHASONE-INDUCED PROGRAMMED CELL-DEATH (APOPTOSIS) IN HUMAN LYMPHOID LEUKEMIA-CELLS
    WOOD, AC
    WATERS, CM
    GARNER, A
    HICKMAN, JA
    BRITISH JOURNAL OF CANCER, 1994, 69 (04) : 663 - 669
  • [25] RELATIONSHIPS BETWEEN THE CELL-CYCLE AND THE EXPRESSION OF C-MYC AND TRANSFERRIN RECEPTOR GENES DURING INDUCED MYELOID DIFFERENTIATION
    BARKER, KA
    NEWBURGER, PE
    EXPERIMENTAL CELL RESEARCH, 1990, 186 (01) : 1 - 5
  • [26] EFFECT OF VERAPAMIL ON CELL-CYCLE TRANSIT AND C-MYC GENE-EXPRESSION IN NORMAL AND MALIGNANT MURINE CELLS
    HUBER, KR
    SCHMIDT, WF
    THOMPSON, EA
    FORSTHOEFEL, AM
    NEUBERG, RW
    ETTINGER, RS
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 714 - 718
  • [27] EXPRESSION AND INVOLVEMENT OF C-FOS AND C-JUN PROTOONCOGENES IN PROGRAMMED CELL-DEATH INDUCED BY GROWTH-FACTOR DEPRIVATION IN LYMPHOID-CELL LINES
    COLOTTA, F
    POLENTARUTTI, N
    SIRONI, M
    MANTOVANI, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (26) : 18278 - 18283
  • [28] PRODUCTION OF HEPATOCELLULAR-CARCINOMA BY OVAL CELLS - CELL-CYCLE EXPRESSION OF C-MYC AND P53 AT DIFFERENT STAGES OF OVAL CELL-TRANSFORMATION
    BRAUN, L
    MIKUMO, R
    FAUSTO, N
    CANCER RESEARCH, 1989, 49 (06) : 1554 - 1561
  • [29] PROSTAGLANDIN-A AND PROSTAGLANDIN-J ARREST THE CELL-CYCLE OF CULTURED VASCULAR SMOOTH-MUSCLE CELLS WITHOUT SUPPRESSION OF C-MYC EXPRESSION
    SASAGURI, T
    MASUDA, J
    SHIMOKADO, K
    YOKOTA, T
    KOSAKA, C
    FUJISHIMA, M
    OGATA, J
    EXPERIMENTAL CELL RESEARCH, 1992, 200 (02) : 351 - 357
  • [30] Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following Vitamin C and Vitamin K3 treatment
    Jamison, JM
    Gilloteaux, J
    Nassiri, MR
    Venugopal, M
    Neal, DR
    Summers, JL
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (02) : 337 - 351